BioSpace News Archive

Experienced attorney to lead high-value intellectual property procurement and protection

Promotion Reflects Vollmer’s Expanding Leadership Role with Company Since its 2014 Founding

Journal of Clinical Oncology Study Shows Natera’s Test is Highly Prognostic and Effective for Recurrence Detection

Canopy Growth Corporation is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company’s ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations, and the most recent addition to Canopy Growth’s medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company, a European leader in cannabinoid-based medical therapies.

Vonage, a global business cloud communications leader, has attained the HITRUST Common Security Framework certification for the cloud-native Vonage Business Cloud unified communications as service platform, ensuring HIPAA compliance with privacy guidelines for protected health information.

Cesca Therapeutics Inc. announced that the Company will release its financial results for the first quarter ended March 31, 2019 on Tuesday, May 14, 2019 after the close of trading.

SY-1365 Currently in Phase 1 Clinical Trial in Relapsed and Treatment-Resistant Ovarian and Breast Cancer Patients

Esteemed academician Dr. John Stockstill to head Research Institute at GSO

The Doctors Company’s commitment to advancing the practice of good medicine will be expanded through a $1 million collaboration that will enable leading UCSF researchers in evidence-based patient safety practices, safety and information technology–related policy, and artificial intelligence (AI) to pursue cutting-edge questions.

Divurgent is excited to announce the addition of Gold Partnership with Microsoft, an honor that distinguishes the firm as a recognized leader in the implementation of Microsoft technologies